Shares of SPCX34.SA slid to $52.43 on July 7, the very day SpaceX officially joins the Nasdaq-100, capping a choppy week that saw the Brazilian Depositary Receipt swing from $58.77 on June 30 to today's price — an 10.8% drawdown in five trading sessions. The pattern is textbook "buy the rumor, sell the news," but the longer-term question for shareholders is whether passive fund demand will provide a durable floor or merely a brief sugar rush. SpaceX DRN Slides 3.5% on Nasdaq-100 Inclusion Day — With the Easy Gains Gone, Can Passive Fund Demand Prop Up a $2 Trillion Valuation?
Shares of SPCX34.SA dropped to $52.43 on July 7, shedding 10.8% in a week as the classic "buy the rumor, sell the news" trade played out around SpaceX's formal addition to the Nasdaq-100. SpaceX joined the index before market open on July 7, 2026 — less than a month after its IPO. For holders of the Brazilian Depositary Receipt, the question now is whether mechanical buying from index funds can absorb profit-taking or whether the stock faces more downside.
• Index Funds Must Buy, but the Dollar Amount May Disappoint
JPMorgan estimates approximately $4.3 billion of SpaceX shares will be purchased by index-tracking funds, including QQQ and QQQM. That sounds large, but SpaceX's index weight lands at only about 1.3% in a benchmark with over $500 billion in QQQ assets alone. Paul Meeks of Freedom Capital Markets called the inclusion "less meaningful than people expect," noting the formula is well-known and already priced in. In short, forced buying exists but is modest relative to the company's ~$2.1 trillion market cap.
• A Tiny Float Makes Prices Swing Wildly in Both Directions
Only about 4% of SpaceX shares were made available during the IPO.
Arete Research warned that ETFs will be buying a "sizeable portion of the tradeable pool," a dynamic that is "likely reflexive on the way up, but potentially fragile on any reversal."
Cboe's JJ Kinahan told CNBC investors should brace for a $20 move in either direction over the next 11 days.
• The Valuation Leaves Almost No Room for Error
SpaceX reported $18.7 billion in 2025 revenue; Morningstar forecasts $36.8 billion for 2026. Even at that growth rate, the stock trades at roughly 78× forward sales — more than three times the most expensive mega-cap peer.
Morningstar's fair value estimate sits at just $62 per share on the U.S. listing, implying the stock remains deeply overvalued by traditional metrics.
• Lockup Expiry Looms as the Next Catalyst — and It Cuts Downward
From late July through August, up to 20% of insiders' shares could become eligible for sale.
SpaceX also cannot enter the S&P 500 until at least mid-2027 , removing the next big wave of forced passive buying from the near-term calendar. For DRN holders, today's dip may not be the last: the stock is caught between shrinking catalysts and a valuation that demands flawless execution for years to come.